FSCN1 and cancer: In multiple types of cancers, in vitro studies demonstrated that overexpression of miRNAs targeting FSCN1 in cancer cell lines reduce cell growth, proliferation, migration, and invasion [91,92,93,94,95,97,99], thus indicating miRNAs or miRNA-based reagents as potential therapeutic options.